Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
MedPage Today on MSN
MicroRNA Tests Eyed for Flagging Heart Transplant Rejection
Panels designed to identify acute cellular rejection, antibody-mediated rejection without ...
Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...
Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.
Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ability to fight Mycobacterium tuberculosis (Mtb), the bacteria responsible ...
Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMR AMR is a leading cause of kidney transplant loss, with ...
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure Second SHORE Study ...
Coherus Oncology (CHRS) announced the publication of preclinical and clinical biomarker research in Molecular Cancer Therapeutics describing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results